QS-ORAL
Live / Registered — Registered (as of 23 Sept 2025)
What this means for you
Registered since 23 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99061621
- Registration number
- 7962739
- Mark type
- Stylized text
- Filed
- 28 Feb 2025
- Registered
- 23 Sept 2025
- Attorney of record
- Rodney L. Skoglund
Goods and services
- Class 005 — Pharmaceuticals: Oral vaccine preparations; Adjuvants for use with vaccines; Adjuvants for medical purposes; Human vaccine preparations; Vaccine adjuvants; Vaccine preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Plant extracts, other than essential oils, for pharmaceutical purposes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of viral diseases
Owner
- Q-VANT Biosciences, Inc., Forestdale, MA, US
- Q-VANT Biosciences, Inc., Forestdale, MA, US
Prosecution history
- 23 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Sept 2025 — REGISTERED-SUPPLEMENTAL REGISTER
- 27 Aug 2025 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 27 Aug 2025 — USE AMENDMENT ACCEPTED
- 26 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Aug 2025 — AMENDMENT TO USE PROCESSING COMPLETE
- 22 Aug 2025 — USE AMENDMENT FILED
- 22 Aug 2025 — TEAS AMENDMENT OF USE RECEIVED
- 04 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Aug 2025 — NON-FINAL ACTION E-MAILED
- 04 Aug 2025 — NON-FINAL ACTION WRITTEN
- 04 Aug 2025 — ASSIGNED TO EXAMINER
- 28 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Feb 2025 — NEW APPLICATION ENTERED